Ginkgo announces to buy Warp Drive Bio’s genome mining platform
Ginkgo Bioworks has announced to acquire the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines. The acquisition will give Gingko access to Warp Drive Bio's genome mining team, technology, and database. This collaboration will help merge biological information and advance its applications in other pharmaceutical industry. The Genome mining platform will augment Ginkgo’s sequencing capabilities, biological codebase, bioinformatics and machine learning tools for gene discovery.
Vertex, Kymera collaborates to develop Protein Degradation Medicine
Vertex Pha...
